Frozen Formulary Legislation Could Raise Rx Costs in Connecticut
(Washington, D.C.) — A new report, prepared by the research firm Milliman for the Pharmaceutical Care Management Association (PCMA), analyzed the financial impact of broad “Frozen Formulary” legislation in the fully insured commercial market on a nationwide basis. This study found